|
1.
|
Dey J, Segars WP, Pretorius PH, Walvick RP, Bruyant PP, Dahlberg S, King MA. Estimation and correction of cardiac respiratory motion in SPECT in the presence of limited-angle effects due to irregular respiration. Med Phys. 2010 Dec; 37(12):6453-65.
|
|
|
|
|
2.
|
Dahlberg ST. Assessment of myocardial perfusion with Tc-99m: image is everything. J Nucl Cardiol. 2009 Jul-Aug; 16(4):493-6.
|
|
|
|
|
3.
|
Tighe DA, Rosetti M, Vinch CS, Chandok D, Muldoon D, Wiggin B, Dahlberg ST, Aurigemma GP. Influence of image quality on the accuracy of real time three-dimensional echocardiography to measure left ventricular volumes in unselected patients: a comparison with gated-SPECT imaging. Echocardiography. 2007 Nov; 24(10):1073-80.
|
|
|
|
|
4.
|
Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Druz RS, Ficaro EP, Galt JR, Garg RK, Germano G, Heller GV, Henzlova MJ, Hyun MC, Johnson LL, Mann A, McCallister BD, Quaife RA, Ruddy TD, Sundaram SN, Taillefer R, Ward RP, Mahmarian JJ. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007 Nov-Dec; 14(6):e39-60.
|
|
|
|
|
5.
|
Hansen CL, Goldstein RA, Berman DS, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Galt JR, Garg RK, Heller GV, Hyun MC, Johnson LL, Mann A, McCallister BD, Taillefer R, Ward RP, Mahmarian JJ. Myocardial perfusion and function single photon emission computed tomography. J Nucl Cardiol. 2006 Nov; 13(6):e97-120.
|
|
|
|
|
6.
|
Feng B, Pretorius PH, Farncombe TH, Dahlberg ST, Narayanan MV, Wernick MN, Celler AM, Leppo JA, King MA. Simultaneous assessment of cardiac perfusion and function using 5-dimensional imaging with Tc-99m teboroxime. J Nucl Cardiol. 2006 May-Jun; 13(3):354-61.
|
|
|
|
|
7.
|
Kupinski MA, Hoppin JW, Krasnow J, Dahlberg S, Leppo JA, King MA, Clarkson E, Barrett HH. Comparing cardiac ejection fraction estimation algorithms without a gold standard. Acad Radiol. 2006 Mar; 13(3):329-37.
|
|
|
|
|
8.
|
Pretorius PH, King MA, Gifford HC, Dahlberg ST, Spencer F, Simon E, Rashkin J, Botkin N, Berndt W, Narayanan MV, Leppo JA. Myocardial perfusion SPECT reconstruction: receiver operating characteristic comparison of CAD detection accuracy of filtered backprojection reconstruction with all of the clinical imaging information available to readers and solely stress slices iteratively reconstructed with combined compensation. J Nucl Cardiol. 2005 May-Jun; 12(3):284-93.
|
|
|
|
|
9.
|
Narayanan MV, King MA, Pretorius PH, Dahlberg ST, Spencer F, Simon E, Ewald E, Healy E, MacNaught K, Leppo JA. Human-observer receiver-operating-characteristic evaluation of attenuation, scatter, and resolution compensation strategies for (99m)Tc myocardial perfusion imaging. J Nucl Med. 2003 Nov; 44(11):1725-34.
|
|
|
|
|
10.
|
Dahlberg S, Leppo J. Risk stratification of the normal perfusion scan: does normal stress perfusion always mean very low risk? J Nucl Cardiol. 2003 Jan-Feb; 10(1):87-91.
|
|
|
|
|
11.
|
Pretorius PH, Narayanan MV, Dahlberg ST, Leppo JA, King MA. The influence of attenuation and scatter compensation on the apparent distribution of Tc-99m sestamibi in cardiac slices. J Nucl Cardiol. 2001 May-Jun; 8(3):356-64.
|
|
|
|
|
12.
|
List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrews F, Schuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Kirkhart B, Bianco JA, Singer JW. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group. Bone Marrow Transplant. 2000 Feb; 25(3):283-91.
|
|
|
|
|
13.
|
Holly TA, Leppo JA, Gilmore MP, Reinhardt CP, Dahlberg ST. The effect of ischemic injury on the cardiac transport of Tc-99m N-NOET in the isolated rabbit heart. J Nucl Cardiol. 1999 Nov-Dec; 6(6):633-40.
|
|
|
|
|
14.
|
Leppo JA, Dahlberg ST. The question: to test or not to test in preoperative cardiac risk evaluation. J Nucl Cardiol. 1998 May-Jun; 5(3):332-42.
|
|
|
|
|
15.
|
Zafrir N, Leppo JA, Reinhardt CP, Dahlberg ST. Thallium reinjection versus standard stress/delay redistribution imaging for prediction of cardiac events. J Am Coll Cardiol. 1998 May; 31(6):1280-5.
|
|
|
|
|
16.
|
Achtert AD, King MA, Dahlberg ST, Pretorius PH, LaCroix KJ, Tsui BM. An investigation of the estimation of ejection fractions and cardiac volumes by a quantitative gated SPECT software package in simulated gated SPECT images. J Nucl Cardiol. 1998 Mar-Apr; 5(2):144-52.
|
|
|
|
|
17.
|
Takahashi N, Dahlberg ST, Gilmore MP, Leppo JA. Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201. J Nucl Cardiol. 1997 Nov-Dec; 4(6):524-31.
|
|
|
|
|
18.
|
Heller LI, Cates C, Popma J, Deckelbaum LI, Joye JD, Dahlberg ST, Villegas BJ, Arnold A, Kipperman R, Grinstead WC, Balcom S, Ma Y, Cleman M, Steingart RM, Leppo JA. Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group. Circulation. 1997 Jul 15; 96(2):484-90.
|
|
|
|
|
19.
|
Pan TS, King MA, Luo DS, Dahlberg ST, Villegas BJ. Estimation of attenuation maps from scatter and photopeak window single photon-emission computed tomographic images of technetium 99m-labeled sestamibi. J Nucl Cardiol. 1997 Jan-Feb; 4(1 Pt 1):42-51.
|
|
|
|
|
20.
|
Zafrir N, Dahlberg ST, Villegas BJ, Leppo JA. Prognostic utility of increased pulmonary thallium uptake in patients without ischemia. J Nucl Cardiol. 1996 Jul-Aug; 3(4):301-7.
|
|
|
|
|
21.
|
Emlein G, Villegas B, Dahlberg S, Leppo J. Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. Am Heart J. 1996 May; 131(5):907-14.
|
|
|
|
|
22.
|
King MA, Luo D, Dahlberg ST, Villegas BJ, Penney BC, Morgan HT. Transmission imaging of large attenuators using a slant hole collimator on a three-headed SPECT system. Med Phys. 1996 Feb; 23(2):263-72.
|
|
|
|
|
23.
|
Heller LI, Villegas BJ, Reinhardt CP, Dahlberg ST, Marcel R, Leppo JA. Teboroxime is a marker of reperfusion after myocardial infarction. J Nucl Cardiol. 1996 Jan-Feb; 3(1):2-8.
|
|
|
|
|
24.
|
King MA, Xia W, deVries DJ, Pan TS, Villegas BJ, Dahlberg S, Tsui BM, Ljungberg MH, Morgan HT. A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agents. J Nucl Cardiol. 1996 Jan-Feb; 3(1):18-29.
|
|
|
|
|
25.
|
Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood. 1995 Feb 15; 85(4):1075-82.
|
|
|
|
|
26.
|
Fabian CJ, Mansfield CM, Dahlberg S, Jones SE, Miller TP, Van Slyck E, Grozea PN, Morrison FS, Coltman CA, Fisher RI. Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study. Ann Intern Med. 1994 Jun 1; 120(11):903-12.
|
|
|
|
|
27.
|
Dahlberg ST, Leppo JA. Physiologic properties of myocardial perfusion tracers. Cardiol Clin. 1994 May; 12(2):169-85.
|
|
|
|
|
28.
|
Dahlberg ST, Gilmore MP, Leppo JA. Interaction of technetium 99m-labeled teboroxime with red blood cells reduces the compound's extraction and increases apparent cardiac washout. J Nucl Cardiol. 1994 May-Jun; 1(3):270-9.
|
|
|
|
|
29.
|
Heller LI, Villegas BJ, Weiner BH, McSherry BA, Dahlberg ST, Leppo JA. Use of sequential teboroxime imaging for the detection of coronary artery occlusion and reperfusion in ischemic and infarcted myocardium. Am Heart J. 1994 Apr; 127(4 Pt 1):779-85.
|
|
|
|
|
30.
|
Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood. 1994 Mar 15; 83(6):1460-6.
|
|
|
|
|
31.
|
Saez R, Dahlberg S, Appelbaum FR, Hartsock RJ, Lemaistre F, Coltman CA, Fisher RI. Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study. Hematol Oncol. 1994 Mar-Apr; 12(2):75-85.
|
|
|
|
|
32.
|
Dahlberg ST, Leppo JA. Myocardial kinetics of radiolabeled perfusion agents: basis for perfusion imaging. J Nucl Cardiol. 1994 Mar-Apr; 1(2 Pt 1):189-97.
|
|
|
|
|
33.
|
Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study. Ann Oncol. 1994; 5 Suppl 2:91-5.
|
|
|
|
|
34.
|
Hendel RC, Dahlberg ST, Weinstein H, Leppo JA. Comparison of teboroxime and thallium for the reversibility of exercise-induced myocardial perfusion defects. Am Heart J. 1993 Oct; 126(4):856-62.
|
|
|
|
|
35.
|
Villegas BJ, Hendel RC, Dahlberg ST, McSherry BA, Leppo JA. Comparison of 3- versus 6-minute infusions of adenosine in thallium-201 myocardial perfusion imaging. Am Heart J. 1993 Jul; 126(1):103-7.
|
|
|
|
|
36.
|
Dahlberg ST, Meerdink DJ, Gilmore MP, Leppo JA. Myocardial extraction of technetium-99m-[2-(1-methoxybutyl) isonitrile] in the isolated rabbit heart: a myocardial perfusion agent with high extraction and stable retention. J Nucl Med. 1993 Jun; 34(6):927-31.
|
|
|
|
|
37.
|
Heller LI, Villegas BJ, Weiner BH, McSherry BA, Dahlberg ST, Leppo JA. Sequential teboroxime imaging during and after balloon occlusion of a coronary artery. J Am Coll Cardiol. 1993 May; 21(6):1319-27.
|
|
|
|
|
38.
|
Weinstein H, Dahlberg ST, McSherry BA, Hendel RC, Leppo JA. Rapid redistribution of teboroxime. Am J Cardiol. 1993 Apr 1; 71(10):848-52.
|
|
|
|
|
39.
|
Alberts DS, Dahlberg S, Green SJ, Garcia D, Hannigan EV, O'Toole R, Stock-Novack D, Surwit EA, Malviya VK, Jolles CJ. Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study. Cancer. 1993 Jan 15; 71(2 Suppl):618-27.
|
|
|
|
|
40.
|
Mittleman RS, Candinas R, Dahlberg S, Vander Salm T, Moran JM, Huang SK. Predictors of surgical mortality and long-term results of endocardial resection for drug-refractory ventricular tachycardia. Am Heart J. 1992 Nov; 124(5):1226-32.
|
|
|
|
|
41.
|
Dahlberg ST, Weinstein H, Hendel RC, McSherry B, Leppo JA. Planar myocardial perfusion imaging with technetium-99m-teboroxime: comparison by vascular territory with thallium-201 and coronary angiography. J Nucl Med. 1992 Oct; 33(10):1783-8.
|
|
|
|
|
42.
|
Voyce SJ, Aurigemma GP, Dahlberg S, Orsinelli D, Pape LA, Sweeney A, Cardullo P, Recht L. A comparison of two-dimensional echocardiography vs carotid duplex scanning in older patients with cerebral ischemia. Arch Intern Med. 1992 Oct; 152(10):2089-93.
|
|
|
|
|
43.
|
Hendel RC, Cohn S, Aurigemma G, Whitfield S, Dahlberg S, Pape L, Leppo J. Focal myocardial injury following blunt chest trauma: a comparison of indium-111 antimyosin scintigraphy with other noninvasive methods. Am Heart J. 1992 May; 123(5):1208-15.
|
|
|
|
|
44.
|
Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study. J Clin Oncol. 1991 Jul; 9(7):1204-9.
|
|
|
|
|
45.
|
Dahlberg ST. Gender difference in the risk factors for sudden cardiac death. Cardiology. 1990; 77 Suppl 2:31-40.
|
|
|
|
|
46.
|
Dahlberg S, Burke M, Gore JM. Bilateral brachial artery emboli presenting as aortic dissection. Arch Intern Med. 1989 Jun; 149(6):1419-20.
|
|
|
|
